Jsmc-10238

ASSOCIATION BETWEEN SERUM TRIGLYCERIDE LEVEL AND CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES MELLITUS 

Taha O. Mahwy a, Karokh Fazil Hamahussien b, and Delman Al-Attar c

a Department of Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq. 

b Kurdistan Board Candidate of Internal Medicine/ Kurdistan Region/ Iraq. 

c Faruk Medical City, Kurdistan Region, Iraq. 

Submitted: 16/5/2019; Accepted: 17/2/2020; Published: 21/3/2020

DOI Link: https://doi.org/10.17656/jsmc.10238 

ABSTRACT

Background 

Diabetes mellitus type 2 is a long-term metabolic disorder that is characterized by high blood sugar, insulin resistance, and a relative lack of insulin. Diabetic kidney disease which is known as diabetic nephropathy is the chronic loss of kidney function occurring in those with diabetes mellitus and is the single strongest predictor of mortality in patients with diabetes. However, in spite of the achievement of recommended targets for blood glucose and blood pressure, the residual risk for diabetic nephropathy remains high among patients with type 2 diabetes. Hypertriglyceridemia may be one of the factors responsible for this high residual risk. Recent studies demonstrated that intra-renal accumulation of lipids may contribute to glomerular injury.

Objectives 

This study aimed to find an association between hypertriglyceridemia and chronic kidney disease in type 2 diabetes mellitus patients.

Patients and Methods

In this cross-sectional study 241 patients evaluated with documented type 2 diabetes mellitus to find any relation between hypertriglyceridemia and chronic kidney disease in type 2 diabetes mellitus. Data collected from 300 patients with type 2 diabetes mellitus, 161 males and 139 females. Of these 59 cases were excluded, 35 males and 24s female patients because of incomplete data was available, with mean age was 54.24 years. laboratory test for measuring fasting (total cholesterol, HDL, LDL, triglyceride, urinary albumin, and urinary creatinine) done using COBAS INTEGRA 400 PLUS (Roche), then ACR measured two samples was obtained.

Results

In our study 139 patients had high serum triglyceride level, the other 102 patients had normal serum triglyceride level. 154 patients had normal urine ACR, (n=77, 50.0%) had high triglyceride level, (n=77, 50.0%) had normal triglyceride level, 57 patients had microalbuminuria, (n=42, 73.7%) had high triglyceride level, (n=15, 26.3%) had normal triglyceride level, 30 patients had macroalbuminuria, (n=20, 66.7%) had high triglyceride level , (n=10, 33.3%) had normal triglyceride level, p-value was significant, (p<0.005) 

Conclusion

In the current study we found that hypertriglyceridemia is an independent risk factor for CKD. Furthermore, hypertension, hypercholesterolemia, high HbA1c and duration of diabetes were also identified as risk factors for CKD.

KEYWORDS

Hypertriglyceridemia, Chronic kidney disease, Diabetes mellitus type 2.

References 

1. "Causes of Diabetes". National Institute of Diabetes and Digestive and Kidney Diseases. June 2014. Archived from the original on 2 February 2016. Retrieved 10 February 2016.

2. Azevedo M, Alla S. Diabetes in sub-Saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa, and Zambia. International journal of diabetes in developing countries. 2008 Oct;28(4):101.

3. Luo Y, Zhang X, Li Y, Deng J, Li X, Qu Y, Lu Y, Liu T, Gao Z, Lin B. High-glucose 3D INS-1 cell model combined with a microfluidic circular concentration gradient generator for high throughput screening of drugs against type 2 diabetes. RSC Advances. 2018;8(45):25409-16.

4. Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. The Journal of clinical investigation. 2014 Jun 2;124(6):2333-40.

5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, AlMazroa MA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2012 Dec 15;380(9859):2095-128.

6. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013 Jul 20;382(9888):260-72.

7. Lewis G, Maxwell AP. Risk factor control is key in diabetic nephropathy. Practitioner. 2014 Feb;258(1768):13-7. 

8. "Diabetes and kidney disease: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2015-06-27.

9. Fioretto P, Dodson PM, Ziegler D, Rosenson RS. Residual microvascular risk in diabetes: unmet needs and future directions. Nature Reviews Endocrinology. 2010 Jan;6(1):19.

10. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH; American Diabetes Association. Diabetic nephropathy. Diabetes Care 2003;26(Suppl. 1): S94–S98.

11. Moorhead JF, El-Nahas M, Chan MK, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. The Lancet. 1982 Dec 11;320(8311):1309-11.

12. Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, Chua S, Levi M. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/DB mice with type 2 diabetes. Diabetes. 2005 Aug 1;54(8):2328-35.

13. Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, Maryniuk M, Peyrot M, Piette JD, Reader D, Siminerio LM. National standards for diabetes self-management education. Diabetes Care. 2009 Jan 1;32(Supplement 1): S87-94.

14. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143.

15. Levey AS, Coresh J, Bolton K, Culleton B, Harvey KS, Ikizler TA, Johnson CA, Krausz A, Kimmel PL, Kusek J, Levin A. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases. 2002;39(2 SUPPL. 1).

16. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 28 (Suppl. 1): S4–S36, 2005

17. World Health Organization, the World Health Organization. Global Observatory for eHealth, WHO Global Observatory for eHealth. Building foundations for eHealth: progress of Member States: report of the WHO Global Observatory for eHealth. World Health Organization; 2006 Dec 6.

18. Zaman SB, Karim MA, Hossain N, Al Kibria GM, Islam SM. Plasma triglycerides as a risk factor for chronic kidney disease in type 2 diabetes mellitus: evidence from northeastern Thailand. Diabetes research and clinical practice. 2018 Apr 1;138:238-45.

19. Lee PH, Chang HY, Hsu YC, Lei CC, Chang HH, Tung CW, Lin CL, Yang HF, Lu LC, Jong MC, Chen CY. Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults. The American journal of the medical sciences. 2009 Sep 1;338(3):185-9.

20. Tan K, Betteridge D, Marmot MG, Talmud P, Humphries SE, Yudkin JS. Hypertriglyceridaemia and vascular risk: Report of a Meeting of Physicians and Scientists, University College London Medical School. The Lancet. 1993 Sep 25;342(8874):781-7.

21. Russo GT, De Cosmo S, Viazzi F, Pacelli A, Ceriello A, Genovese S, Guida P, Giorda C, Cucinotta D, Pontremoli R, Fioretto P. Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative. Diabetes Care. 2016 Dec 1;39(12):2278-87.

22. Shimizu Y, Sato S, Komatsu J, Yamanashi H, Nagayoshi M, Kadota K, Maeda T. Association of chronic kidney disease and diabetes with triglycerides-to-HDL cholesterol ratio for a Japanese population: The Nagasaki Islands Study. Transl Med. 2014;4(124):1-4.

23. Han E, Yun Y, Kim G, Lee YH, Wang HJ, Lee BW, Cha BS, Kim BS, Kang ES. Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia. PLoS One. 2016 May 2;11(5):e0154683.

24. National Institute for Health and Clinical Excellence (NICE). Chronic kidney disease. [online]. Available at http://www.nice.org.uk/cg73 (last accessed 25 July 2013).

25. 83 Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of chronic kidney disease. [online]. Available at http://www.sign.ac.uk/guidelines/fulltext/103/ (last accessed 25 July 2013).

26. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, Levey AS. Evaluation of the modification of diet in renal disease study equation in a large diverse population. Journal of the American Society of Nephrology. 2007 Oct 1;18(10):2749-57.

27. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, Levey AS. Evaluation of the modification of diet in renal disease study equation in a large diverse population. Journal of the American Society of Nephrology. 2007 Oct 1;18(10):2749-57.

28. Zhang, Zhiwei. "Benign Hypertensive Arteriolar Nephrosclerosis". Merck Manuals Consumer Version. Retrieved 2016-11-12.

29. "Hypertensive Nephropathy, Symptoms, Treatment, Diet, and Causes – Kidney Disease Symptoms and Treatment". www.kidney-symptom.com. Retrieved 2016-11-12.

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.